Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2016, Article ID 4810901, 3 pages
http://dx.doi.org/10.1155/2016/4810901
Case Report

Pericardial Effusion due to Primary Malignant Pericardial Mesothelioma: A Common Finding but an Uncommon Cause

1Department of Internal Medicine C, Hillel Yaffe Medical Center, Hadera, Affiliated to Technion, Haifa, Israel
2Department of Cardiology, Hillel Yaffe Medical Center, Hadera, Affiliated to Technion, Haifa, Israel
3Department of Thoracic Surgery, Rambam Medical Center Affiliated to Technion, Haifa, Israel

Received 13 July 2016; Revised 25 August 2016; Accepted 29 August 2016

Academic Editor: Jagdish Butany

Copyright © 2016 Valery Istomin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Cohen, “Neoplastic pericarditis,” Cardiovascular Clinics, vol. 7, no. 3, pp. 257–269, 1976. View at Google Scholar
  2. G. Hillerdal, “Malignant mesothelioma 1982: review of 4710 published cases,” British Journal of Diseases of the Chest, vol. 77, no. 4, pp. 321–343, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Luk, E. Ahn, P. Vaideeswar, and J. W. Butany, “Pericardial tumors,” Seminars in Diagnostic Pathology, vol. 25, no. 1, pp. 47–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. N. J. Vogelzang, J. J. Rusthoven, J. Symanowski et al., “Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma,” Journal of Clinical Oncology, vol. 21, no. 14, pp. 2636–2644, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. G. L. Ceresoli, P. A. Zucali, A. G. Favaretto et al., “Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma,” Journal of Clinical Oncology, vol. 24, no. 9, pp. 1443–1448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Zalcman, J. Mazieres, J. Margery et al., “Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial,” The Lancet, vol. 387, pp. 1405–1414, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Fujimoto, K. Gemba, S. Wada et al., “Malignant pericardial mesothelioma with response to chemotherapy,” Journal of Thoracic Oncology, vol. 4, no. 11, pp. 1440–1441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. K. A. Reardon, M. A. Reardon, C. A. Moskaluk, W. W. Grosh, and P. W. Read, “Primary pericardial malignant mesothelioma and response to radiation therapy,” Rare Tumors, vol. 2, no. 3, article e51, 2010. View at Publisher · View at Google Scholar · View at Scopus